Analysts Set Janux Therapeutics, Inc. (NASDAQ:JANX) Target Price at $62.67
Shares of Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the sixteen analysts that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, twelve have given a buy recommendation and […]
16 Dec 04:34 · The Cerbat Gem